A recent UK judgment is good news for owners of patents claiming large numbers of compounds
But IAM research shows the NPE led by Boris Teksler is facing a barrage of Chinese invalidity actions from both ZTE and its co-defendant Huawei.
A country-by-country analysis warns of uneven ground in the standards landscape Read more
How the appeals brought by Huawei and ZTE could upend the licensing market Read more
The availability of injunctive relief varies widely around the world. In our first analysis of the global injunction landscape we lift the lid on which jurisdictions provide the best opportunity for a sales ban Read more
@IAM_Alerts This week's Sunday Supplement is now out, including: EPO top for quality; Vidal’s SEP hostage to fortune; Calls for… https://t.co/3Nk4AR1Ikt Read more
@IAM_Alerts Saturday Opinion: top in-house professionals from Australia say country is systematically under-investing in IP… https://t.co/UaqE1uV8TU Read more
@IAM_Alerts The CAFC tees up a patent fight over Moderna's multi-billion-dollar covid-19 revenues. Arbutus and Roivant shares s… https://t.co/i87DzyZpkP Read more
@IAM_Alerts Huawei knocks out licensing company's Chinese patents as the pair continue global SEP dispute… https://t.co/1b8yaR9g28 Read more
